You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

NITROFURANTOIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Nitrofurantoin patents expire, and what generic alternatives are available?

Nitrofurantoin is a drug marketed by Actavis Labs Fl Inc, Alembic, Athem, Aurobindo Pharma Usa, Impax Labs Inc, Mankind Pharma, Novel Labs Inc, Sun Pharm Industries, Watson Labs, Zydus Pharms, Actavis Mid Atlantic, Amneal Pharms, Aurobindo Pharma, Nostrum Labs Inc, Novitium Pharma, Elkins Sinn, Ivax Sub Teva Pharms, Sandoz, Whiteworth Town Plsn, Alvogen, Chartwell Rx, Inventia, Micro Labs, Ranbaxy Labs Ltd, Sunny, and Watson Labs Inc. and is included in thirty-nine NDAs.

The generic ingredient in NITROFURANTOIN is nitrofurantoin; nitrofurantoin, macrocrystalline. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the nitrofurantoin; nitrofurantoin, macrocrystalline profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NITROFURANTOIN?
  • What are the global sales for NITROFURANTOIN?
  • What is Average Wholesale Price for NITROFURANTOIN?
Summary for NITROFURANTOIN
Drug patent expirations by year for NITROFURANTOIN
Drug Prices for NITROFURANTOIN

See drug prices for NITROFURANTOIN

Drug Sales Revenue Trends for NITROFURANTOIN

See drug sales revenues for NITROFURANTOIN

Recent Clinical Trials for NITROFURANTOIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MinnesotaEarly Phase 1
Walter Reed National Military Medical CenterPhase 2
Goodlife Pharma B.V.Phase 4

See all NITROFURANTOIN clinical trials

Pharmacology for NITROFURANTOIN
Medical Subject Heading (MeSH) Categories for NITROFURANTOIN

US Patents and Regulatory Information for NITROFURANTOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz NITROFURANTOIN nitrofurantoin TABLET;ORAL 080043-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms NITROFURANTOIN nitrofurantoin SUSPENSION;ORAL 201679-001 May 11, 2011 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Amneal Pharms NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) nitrofurantoin; nitrofurantoin, macrocrystalline CAPSULE;ORAL 207372-001 May 15, 2017 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.